Navigation Links
Georgetown University Medical Center licenses 'theranostic' for development

WASHINGTON, D.C. Georgetown University Medical Center (GUMC) has licensed worldwide rights of a potential novel cancer therapy and diagnostic, or "theranostic," to BioMetrx, LLC. The agent was invented by two Georgetown researchers.

GUMC's license agreement with BioMetrx, LLC, a Maryland-headquartered biotechnology company, expedites the translation of the agent, Rasstore, from the laboratory to the clinical setting for further investigation as a potential new therapy.

Rasstore is named for the novel way it could potentially restore the body's natural ability to suppress tumor cells, utilizing the tumor suppressor gene RASSF1A. The agent was invented by Milton Brown, M.D., Ph.D., director of GUMC's Drug Discovery Program, and Partha Banerjee, Ph.D., a world recognized expert on RASSF1A and tumor suppression, also at GUMC.

"It's rewarding for Partha and me to see an agent progress from concept to where we are today on the verge of completing pre-clinical IND enabling studies for a new agent which we believe has applications in prostate cancer and possibly other cancers as well," said Brown, who holds the Edwin H. Richard and Elisabeth Richard von Matsch Endowed Chair in Experimental Therapeutics and is an associate professor at Georgetown Lombardi Comprehensive Cancer Center.

"Rasstore exemplifies the high-quality, early-stage technologies emerging from Georgetown's robust drug discovery program," says Claudia Stewart, vice president of technology commercialization at Georgetown. "Our commercial relationship with BioMetrx represents the process in universities that harnesses the enthusiasm of seasoned entrepreneurs who form a company around the technology, raise funds and then leverage the technical expertise of the inventors to advance the technology...the start up process."

BioMetrx has begun raising the capital required to support clinical investigation.

"We believe Rasstore will be very attractive to other pharmaceutical companies," says John Wells, BioMetrx's Executive Vice President for Global Operations. "This agent has the potential to enhance existing therapeutics because of its potential to restore the body's natural tumor suppression capability."


Contact: Karen Mallet
Georgetown University Medical Center

Related medicine news :

1. Georgetown University Center for Children and Families Hails Health Reform As Big Win for Children and Families
2. Georgetown Research Center Helps Reporters Decipher Health Reform Law & Impact on State Residents
3. FDA and Georgetown University Medical Center announce partnership
4. Georgetown research identifies key reasons racial disparities exist in emergent stroke treatment
5. FDA awards Georgetown University a Center of Excellence in Regulatory Science & Innovation
6. Georgetown researchers examine 21-year series of nipple sparing mastectomy cases and find no cancers
7. Georgetown professor applauds decision of researchers to temporarily halt research on H5N1
8. University of Virginia Health System Medical Laboratories Selects Sunquest's Specimen Collection Solution
9. Akron Institute of Herzing University Launches Its First Bachelors Degree Programs to Prepare Students for Even Greater Success in Business, Health Care and IT
10. Most pandemic plans in Ontario hospitals have not been tested: Queens University study
11. San Diego State University and BIOCOM Institute Receive $4.95 Million Grant: The BRIDGE Project, Linking Education to Employment in San Diegos Life Sciences Industry
Post Your Comments:
(Date:11/25/2015)... ... November 25, 2015 , ... ... and athletic programs, launches new Wimbledon Athletics Facebook page to educate ... athletes for unsuspected cardiac abnormalities. About 2,000 people under the age of 25 ...
(Date:11/25/2015)... ... November 25, 2015 , ... The McHenry County law ... successful appellate decision obtained by Attorneys Francisco J. Botto and Alex C. Wimmer. Attorneys ... Workers’ Compensation Comm’n, 2015 IL App (2d) 130884WC. , According to court documents, Adcock ...
(Date:11/25/2015)... ... ... On November 23rd 2015 Cozy Products, a division of Bird-X ... Products explains what this means for business moving forward. , The Tri Lite heater ... model: to sell personal heaters that reduce energy consumption, are economical and keep people ...
(Date:11/25/2015)... ... November 25, 2015 , ... Smiles by Stevens ... Bruxism, and moderate facial wrinkling. While many patients are aware of the benefits of ... success Botox® delivers to those suffering with discomfort, soreness, and pain as a result ...
(Date:11/25/2015)... ... November 25, 2015 , ... ... board certified facial plastic surgeon specializing in both surgical and non-surgical treatments, announced ... Skin Spa at Hobgood Facial Plastic Surgery. , Highly trained and nationally ...
Breaking Medicine News(10 mins):
(Date:11/25/2015)... -- ARKRAY USA , Inc., a leader ... the accuracy of its blood glucose meter systems. Last ... and Cardiovascular Disease in Los Angeles ... 01 meter and the Assure ® Prism ... accurately measure glucose levels in blood is essential for ...
(Date:11/25/2015)... 2015  Henry Schein, Inc., the world,s largest provider ... medical and animal health practitioners, will unveil at the ... Schein ConnectDental® Pavilion , which brings together for the ... designed to help any practice or laboratory enter the ... a schedule of experts appearing at the Pavilion. ...
(Date:11/25/2015)... Israel , November 25, 2015 ... KTOV ) (TASE: KTOV), a biopharmaceutical company focused ... treatment of various clinical conditions, today announced the closing ... American Depository Shares ( ADSs ), each representing 20 ... up to 3,158,900 ADSs. The ADSs and warrants were ...
Breaking Medicine Technology: